Navigation Links
Daily multivitamin use does not reduce cardiovascular disease risk in men
Date:11/5/2012

Boston, Mass. Approximately one-third of Americans take a daily multivitamin, but little is known about a multivitamin's long-term affect on chronic diseases. Now, new research from Brigham and Women's Hospital (BWH) finds that daily multivitamin use does not reduce the risk of cardiovascular disease in men. A similar BWH study, announced last month, found daily multivitamin use can reduce a man's risk of cancer by 8 percent. The cardiovascular disease findings will be presented Nov. 5 at the American Heart Association's Scientific Sessions 2012 and published simultaneously in the Journal of the American Medical Association.

"The findings from our large clinical trial do not support the use of a common daily multivitamin supplement for the sole purpose of preventing cardiovascular disease in men," said Howard D. Sesso, ScD, lead author and an associate epidemiologist in the Division of Preventive Medicine at BWH. "The decision to take a daily multivitamin should be made in consultation with one's doctor and consideration given to an individual's nutritional status and other potential effects of multivitamins, including the previously reported modest reduction in cancer risk."

Researchers enrolled nearly 15,000 men over the age of 50 in the study and followed them for more than 10 years. The men were randomly assigned to take either a multivitamin or a placebo every day which ensured that both treatment groups were identical with respect to risk factors for cardiovascular disease. The men self-reported episodes of heart attacks, strokes and cardiovascular disease, and a panel of physicians reviewed and confirmed their events with medical records. Researchers then compared the group that took the multivitamin with the group that took the placebo and found no significant impact on risk of heart attack, stroke, or cardiovascular mortality. Additionally, the effect of a daily multivitamin on major cardiovascular events did not differ on participants with a baseline history of cardiovascular disease and those who were initially free of cardiovascular disease.

J. Michael Gaziano, MD, chief of the Division of Aging at BWH, investigator at VA Boston and senior author of the study, said, "Since so many Americans take daily multivitamins, studies like this are key to providing us with valuable information about what specific benefits multivitamins do or do not provide in terms of their long-term impact on chronic diseases. For cardiovascular disease, we must continue to emphasize a heart-healthy diet, physical activity, smoking cessation and regular screening for cardiovascular risk factors."


'/>"/>

Contact: Tom Langford
tlangford@partners.org
617-534-1605
Brigham and Women's Hospital
Source:Eurekalert

Related biology news :

1. Research provides new insights into dogs natural feeding behavior and finds they target a daily dietary intake that is high in fat
2. 30 minutes of daily exercise does the trick
3. Rats recall past to make daily decisions
4. Fish oil added to yogurt may help consumers meet daily nutritional requirements
5. USDA patents method to reduce ammonia emissions
6. Clinical hypnosis can reduce hot flashes after menopause, Baylor study shows
7. Eating well during pregnancy reduces babys obesity risk regardless of moms size
8. Studies shed light on how to reduce the amount of toxins in plant-derived foods
9. UC Santa Cruz study shows how sea otters can reduce CO2 in the atmosphere
10. Study in mice discovers injection of heat-generating cells reduces belly fat
11. Fast food restaurant lighting and music can reduce calorie intake and increase satisfaction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , December 1, 2016 ... (Fingerprint, Voice), Future Technology (Iris Recognition System), Vehicle ... - Global Forecast to 2021", published by MarketsandMarkets, ... Million in 2016, and is projected to grow ... CAGR of 14.06%.      (Logo: http://photos.prnewswire.com/prnh/20160303/792302) ...
(Date:11/30/2016)... 2016 Not many of us realize that we spend ? of our ... need to do it well. Inadequate sleep levels have been found to lead to ... and even cancer. Maybe now is the best time to rethink how ... to manage their sleep quality? Continue Reading ... ...
(Date:11/29/2016)... BioDirection, a privately held medical device company ... detection of concussion and other traumatic brain injury (TBI), ... meeting with the U.S. Food and Drug Administration (FDA) ... During the meeting company representatives reviewed plans for clinical ... commencement of a planned pilot trial. ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... ... December 08, 2016 , ... ... for their exceptionally efficient human mesenchymal stem/stromal cell (hMSC) expansion medium. ... media products engineered to radically streamline culture processes, minimize processing time, significantly ...
(Date:12/8/2016)... 2016  HedgePath Pharmaceuticals, Inc. (OTCQX: HPPI), a ... plans to commercialize innovative therapeutics for patients with ... were approved for trading on the OTCQX U.S. ... OTCQX, effective today, under the ticker symbol "HPPI." ... companies must meet high financial standards, follow best ...
(Date:12/7/2016)... ... 07, 2016 , ... ACEA Biosciences, Inc. presented today updated ... trial for its lead drug candidate, AC0010, at the World Conference on Lung ... determine the safety, antitumor activity, and recommended phase II dosage of AC0010 in ...
(Date:12/7/2016)... 7, 2016 /PRNewswire/ - Zenith Capital Corp. ("Zenith" or the "Company") ... presented at the Company,s Annual and Special Meeting. ... take place on Thursday, December 15, 2016 at ... (Room EC1040), 4825 Mount Royal Gate SW, Calgary, ... of meeting and management information circular, containing the matters to ...
Breaking Biology Technology: